Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interleukin 6 (IL-6)].

K Dohi1, M Iwano, Y Horii

  • 11st Dept of Internal Medicine, Nara Medical University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Diagnostic significance of urinary immunoglobulin G in diabetic nephropathy].

Nihon Jinzo Gakkai shi·2000
Same author

[An elderly case of triple-vessel coronary artery disease with alternating bundle branch blocks in serial electrocardiograms].

Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·1999
Same author

[A case of systemic lupus erythematosus discovered from left heart failure due to lupus induced mitral regurgitation].

Ryumachi. [Rheumatism]·1999
Same author

The effect of cardiac arrest on the permeability of the mouse blood-brain and blood-spinal cord barrier to pituitary adenylate cyclase activating polypeptide (PACAP).

Peptides·1999
Same author

Brain metastasis from hepatocellular carcinoma after radical hepatectomy.

Hiroshima journal of medical sciences·1999
Same author

Ultrasonic tissue characterization in patients with dilated cardiomyopathy: comparison with findings from right ventricular endomyocardial biopsy.

International journal of cardiac imaging·1999
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Interleukin 6 (IL-6) plays a key role in immune responses and is implicated in chronic inflammatory diseases. This study suggests IL-6 is closely linked to the development of mesangial proliferative glomerulonephritis (mes PGN).

Area of Science:

  • Immunology
  • Nephrology
  • Molecular Biology

Context:

  • Interleukin 6 (IL-6) is a crucial cytokine involved in immune regulation, acute phase responses, and hematopoiesis.
  • Dysregulated IL-6 production is implicated in various chronic inflammatory conditions.
  • IL-6 acts as an autocrine growth factor for mesangial cells.

Purpose:

  • To investigate the role of IL-6 in the pathogenesis of mesangial proliferative glomerulonephritis (mes PGN).

Summary:

  • IL-6 was found in the kidney's mesangial areas.
  • Intraglomerular mRNA expression of the IL-6 gene was detected in patients with mes PGN.
  • Mesangial proliferation was observed in IL-6 transgenic mice, supporting IL-6's role.

Impact:

Related Experiment Videos

  • These findings highlight IL-6 as a significant factor in the development of mes PGN.
  • Suggests potential therapeutic targets for mes PGN by modulating IL-6 activity.